Company Profile

Instapath Inc (AKA: Instapath Bioptics)
Profile last edited on: 8/23/2021      CAGE: 821P4      UEI: HJKWKQUCJLC3

Business Identifier: Digital imaging tools for rapid on-site pathology evaluation
Year Founded
2017
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5855 Marcia Avenue
New Orleans, LA 70124
   (504) 810-6152
   info@instapathbio.com
   www.instapathbio.com
Location: Single
Congr. District: 01
County: Orleans Parish

Public Profile

Instapath Inc. is a medical device firm organized around digital imaging tools for rapid on-site pathology evaluation to deterine and enable repeat biopsy procedures if required. Currently resident in JLab Houston facilites, the firm has designed a microscopy system that provides an image of cancer biopsies. Within seconds, the system provides imaging biopsy samples upon removal at sub cellular resolution - but also effectively preserves the tissue for future analysis - enabling essential biopsy quality evaluation to ensure an accurate final diagnosis. It is estimated that every year several million Americans need biopsy procedures every year with some 20% of procedures failing to render an accurate diagnosis with patients having to go through costly, painful repeat biopsy procedures. The firm's system improves rapid on-site evaluation (ROSE) of biopsies teducing the need for repeat procedures and making for more ffectie use of operating room capacity. A mobile application for image viewing and annotation allows for fast and centralized remote pathology evaluation on all common devices

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NSF $1,225,000
Project Title: An Automated Digital Pathology Lab for Rapid On-Site Processing and Imaging of Tissue Biopsies

Key People / Management

  Mei Wang -- Founder and CEO

  J Quincy Brown -- Chief Research Officer

  Tulman David -- Chief Clinical Officer

  Pete Lawson -- Chief Technology Officer

  Tom Szymczyk -- Embedded System Engineer